Shalev V, et al. Arch Intern Med 2009; 169:260-268

Characteristics of Adults Initiating a New Treatment With a Statin Agent, Maccabi Healthcare Services, Israel, 1998-2006 – Part I

Shalev V, et al. Arch Intern Med 2009; 169:260-268

Shalev V, et al. Arch Intern Med 2009; 169:260-268

Characteristics of Adults Initiating a New Treatment With a Statin Agent, Maccabi Healthcare Services, Israel, 1998-2006 – Part II

Shalev V, et al. Arch Intern Med 2009; 169:260-268

Association Between Potential Determinants and All-Cause Mortality, Maccabi Healthcare Services, Israel, 1998-2006

Shalev V, et al. Arch Intern Med 2009; 169:260-268

Proportional effects of continuation of statins on reduction in all-cause mortality per 10% proportion of days covered with statins in primary

prevention (A) and secondary prevention (B) cohorts

Shalev V, et al. Arch Intern Med 2009; 169:260-268

Proportion of Days Covered With Statins and All-Cause Mortality, Maccabi Healthcare Services, Israel, 1998-2006

Shalev V, et al. Arch Intern Med 2009; 169:260-268

Hazard ratios and 95% confidence

intervals of all-cause mortality according

to proportion of days covered with statins in primary prevention (A) and

secondary prevention (B)

cohorts, Maccabi Healthcare Services,

Israel, 1998-2006